title: Plans Favor Product Preferencing To Tame Spending on Biologics.
abstract: Historically, it's rare for commercial payers to have drug formularies for medical benefits, but that's changing. In effect, health plans are, in some ways, choosing drugs they prefer, based on their judgments about safety and efficacy, as well as availability, lowest net cost, and how a drug is administered.
authors.forename: Ed
authors.initials: E
authors.lastname: Silverman
mesh_terms: D001688:Biological Products; D003365:Costs and Cost Analysis; D016527:Drug Costs; D005569:Formularies as Topic; D014481:United States
chemical_list: D001688:Biological Products